Article info

Download PDFPDF
Inefficacy of infliximab in ankylosing spondylitis is correlated with antibody formation
  1. Correspondence to:
    Dr M K de Vries
    Department of Rheumatology, VU University Medical Centre, Room 4A-42, PO Box 7057, 1007 MB Amsterdam, The Netherlands; mk.devries{at}vumc.nl
View Full Text

Citation

de Vries MK, Wolbink GJ, Stapel SO, et al
Inefficacy of infliximab in ankylosing spondylitis is correlated with antibody formation

Publication history

  • Accepted June 5, 2006
  • First published December 18, 2006.
Online issue publication 
December 18, 2006

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.